Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study — Ilaria Cetta (2022) | RDL Network
Kristine A. Frerichs, Christie P.M. Verkleij, Meletios A Dimopoulos, Jhon A. Marin Soto, Sonja Zweegman, Mary H. Young, Kathryn J. Newhall, Tuna Mutis, Niels W.C.J. van de Donk
Robin L. Jones, Teresa Macarulla, John A. Charlson, Brian Andrew Van Tine, Lipika Goyal, Antoîne Italiano, Christophe Massard, Mark Rosenthal, Macarena I. de la Fuente, Patricia Roxburgh, Madappa N. Kundranda, Jean Yves Blay, Changhoon Yoo, Kate Lipford, Sanjeev Forsyth, Sylvie M. Guichard, Yelena Mikhailov, Blythe Thomson, Patrick Kelly, Florence Duffaud
Discussion(0)
No comments yet. Be the first to comment.